Managing relapsed refractory lymphoma with palliative oral chemotherapy: A multicentre retrospective study

Managing relapsed refractory lymphoma with palliative oral chemotherapy: A multicentre retrospective study

Abstract PEP‐C (prednisolone, etoposide, procarbazine and cyclophosphamide) is an orally administered daily chemotherapy regimen used with palliative intent in relapsed refractory lymphoma. To our knowledge, no data on PEP‐C have been reported since the original group described the regimen. Here we...

Full description

Bibliographic Details
Main Authors: Simon J. Bulley, Anna Santarsieri, Isabel C. Lentell, Brendan O'Sullivan, Andrew Hodson, Oliver Firth, Shalal Sadullah, Annabel M. Follows, Mamatha Karanth, Sandra Young Min, Alexis Fowler, James Russell, Benjamin J. Uttenthal, Daniel J. Hodson, George A. Follows
Format: Article
Language:English
Published: Wiley 2022-11-01
Series:eJHaem
Online Access:https://doi.org/10.1002/jha2.537

Internet

https://doi.org/10.1002/jha2.537

Similar Items